Clinical Case Reports (Dec 2022)

Rifampin‐induced acute kidney injury and hemolysis: A case report and literature review of a rare condition

  • Fateen Ata,
  • Hiba M. B. Magboul,
  • Haneen A. A. Toba,
  • Hadeel Alfar,
  • Adel Al Bozom,
  • Khaled Murshed,
  • Muhammad Zahid

DOI
https://doi.org/10.1002/ccr3.6780
Journal volume & issue
Vol. 10, no. 12
pp. n/a – n/a

Abstract

Read online

Abstract Rifampicin is a bactericidal drug used in various infectious diseases, including tuberculosis (TB). Nephrotoxicity is a rare side effect of intermittent Rifampin use and even less commonly continued use. We report a case of Rifampin‐induced acute tubular necrosis and hemolysis in a patient with latent TB with a relevant literature review.

Keywords